Pharming Wins EU Approval for Joenja in Rare Disease
Leiden, Netherlands, May 22, 2026 Pharming Group N.V. has announced that the European Commission (EC) has granted Marketing Authorization...
Joenja
Advertisement
Pharming’s Joenja Wins CHMP Nod for APDS in EU
LEIDEN, Netherlands, March 27, 2026 Pharming Group N.V. announced that the Committee for Medicinal Products for Human Use (CHMP)...
Pharming Group Secures Japan Approval for Joenja in APDS
LEIDEN, NETHERLANDS, March 24, 2026 Pharming Group has announced that Japan’s Ministry of Health, Labour and Welfare has approved...
FDA Issues CRL for Pediatric Joenja in Rare Immunodeficiency
LEIDEN, Netherlands, Feb. 1, 2026 — Pharming Group announced that the U.S. Food and Drug Administration (FDA) has issued...
Advertisement
